After several recent reports of patient injuries associated with the use of defective or unsterile reprocessed single-use medical devices, Rep. Waxman and Chairman Davis write to GAO and to FDA's Acting Commissioner von Eschenbach to request information regarding the adequacy of FDA's oversight of these devices, and how it compares that of single-use devices.